Table 2.
Clinicopathologic factors associated with UNC13C expression.
| UNC13C | ||||
|---|---|---|---|---|
| Factors | Low no. (n = 190) | High no. (n = 67) | *aOR (95% CI)a | P-value |
| Tumor size (SD) | 3.06 (1.62) | 2.93 (1.53) | ||
| T Classification | ||||
| I/II | 102 | 43 | 1 | |
| III/IV | 88 | 24 | 0.65 (0.36–1.15) | 0.3638 |
| N (Lymph node) | ||||
| N0/N1 | 146 | 54 | 1 | |
| N2/N3 | 44 | 13 | 0.79 (0.36–1.60) | 0.4 |
| M (Metastasis) | ||||
| No | 189 | 67 | 1 | |
| Yes | 1 | 0 | ND | |
| AJCC Cancer stage | ||||
| Early stage (I/II) | 71 | 36 | 1 | |
| Advance stage (III/IV) | 119 | 31 | 0.51 (0.29–0.86) | 0.002 |
| Histological grade | ||||
| Well | 31 | 10 | 1 | 0.184 |
| Moderate/poor | 159 | 57 | 1.09 (0.49–2.49) | |
| Death | ||||
| No | 104 | 48 | 1 | |
| Yes | 86 | 19 | 0.47 (0.25–0.85) | 0.0134 |
a
Adjusted odds ratio (aOR) was controlled for gender and age.
*
P < 0.05; ND, not determined.